Skip to main content

Table 1 Patient characteristics (N = 31)

From: A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

  Number of patients %
Sex
 Male 24 77.4
 Female 7 22.6
ECOG PS
 0–1 27 87.1
 2 4 12.9
Clinical Stage
 IIIB 10 32.2
 IV 11 35.6
 Recurrence 10 32.2
Histological type
 Adenocarcinoma 16 51.6
 Squamous cell carcinoma 12 38.7
 Not specified 3 9.7
Smoking history
 Smoker 25 80.6
 Non-smoker 6 19.4
No. of prior treatment regimen
 1 14 45.1
 2 7 22.5
 3 or more 10 32.4
  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, PS performance status